SCHEMBL19230375

SCHEMBL19230375

COC(=O)c1ccc2c(c1)CCC(c1ccc(O)cc1F)O2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 4/20 0.46
ESR1 P03372 3/20 0.46
SLC8A1 P32418 3/20 0.39
RAB9A P51151 1/20 0.38
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
NISCH Q9Y2I1 1/20 0.37
FFAR1 O14842 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19230577 0.88 KDM4E (0.44) SLC8A1CA1CA2FFAR1ABCB11
SCHEMBL19230993 0.88 ESR1 (0.47) ESR2ESR1SLC8A1RAB9APDK1
SCHEMBL19230805 0.87 ESR1 (0.49) ESR2ESR1RAB9APDK1PDK2
SCHEMBL19230656 0.87 ESR1 (0.49) ESR2ESR1RAB9APDK1PDK2
SCHEMBL19230310 0.87 ESR1 (0.49) ESR2ESR1RAB9APDK1PDK2
SCHEMBL19230992 0.86 ESR2 (0.44) ESR2ESR1SLC8A1RAB9APDK1
SCHEMBL19230616 0.83 ESR2 (0.65) ESR2ESR1SLC8A1RAB9ACA12
SCHEMBL24102062 0.79 CA12 (0.43) SLC8A1RAB9APDK2CA12CA1
SCHEMBL19230370 0.79 SLC8A1 (0.37) ESR2ESR1SLC8A1RAB9ACHRNB2
SCHEMBL19230991 0.78 SLC8A1 (0.43) SLC8A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602811-B FXR receptor agonists 轩竹生物科技有限公司 2021-11-16 CN disclosed
WO-2017133521-A1 FXR RECEPTOR AGONIST 山东轩竹医药科技有限公司 2017-08-10 WO disclosed